• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部用载有吡非尼酮的脂质体眼用制剂可减少小鼠角膜碱烧伤后的混浊形成。

Topical Pirfenidone-Loaded Liposomes Ophthalmic Formulation Reduces Haze Development after Corneal Alkali Burn in Mice.

作者信息

Diaz-Palomera Carlos Daniel, Vidal-Paredes Isaac Alejandro, Navarro-Partida Jose, Cid-Hernandez Margarita, Rosales-Rivera Luis Carlos, De la Rosa-Bibiano Ricardo, Monroy-Ramirez Hugo Christian, Santos Arturo, Armendariz-Borunda Juan

机构信息

Instituto de Biologia Molecular en Medicina y Terapia Genica, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.

Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Monterrey 64849, Nuevo Leon, Mexico.

出版信息

Pharmaceutics. 2022 Jan 28;14(2):316. doi: 10.3390/pharmaceutics14020316.

DOI:10.3390/pharmaceutics14020316
PMID:35214048
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8875218/
Abstract

Corneal chemical burns (CCBs) frequently result in corneal fibrosis or haze, an opacity of the cornea that obstructs vision and induces corneal blindness. Diverse strategies have been employed to prevent or reduce CCB-related corneal haze. In this study, we evaluated the physicochemical characteristics and biologic effects of a topical pirfenidone (PFD)-loaded liposomal formulation (PL) on a corneal alkali burn mice model. We found that PL was appropriate for ocular application due to its physiologic tear pH, osmolarity and viscosity suitable for topical ophthalmic use. Regarding its therapeutic activity, PL-treated mice had significantly reduced haze size and density, corneal edema, corneal thickness, and corneal inflammatory infiltration, in contrast to PFD in aqueous solution ( < 0.01). Importantly, the antifibrotic activity of PL (reduction of corneal haze) was associated with modulation of transforming growth factor (TGF)-β and Interleukin (IL)-1β genes. PL suppressed TGF-β expression and restored normal IL-1β expression in corneal tissue more efficiently in contrast to PFD in aqueous solution. In conclusion, PFD showed essential anti-inflammatory and anti-fibrotic effects in the treatment of alkali burns. Noteworthy, a new formulation of PFD-loaded liposomes remarkably improved these effects, standing out as a promising treatment for corneal haze.

摘要

角膜化学烧伤(CCB)常导致角膜纤维化或混浊,即角膜出现混浊,阻碍视力并导致角膜盲。人们采用了多种策略来预防或减少与CCB相关的角膜混浊。在本研究中,我们评估了局部应用载有吡非尼酮(PFD)的脂质体制剂(PL)对角膜碱烧伤小鼠模型的物理化学特性和生物学效应。我们发现PL因其生理泪液pH值、渗透压和粘度适合局部眼科应用,所以适合眼部给药。关于其治疗活性,与水溶液中的PFD相比(P<0.01),PL治疗的小鼠的混浊大小、密度、角膜水肿、角膜厚度和角膜炎症浸润均显著降低。重要的是,PL的抗纤维化活性(减少角膜混浊)与转化生长因子(TGF)-β和白细胞介素(IL)-1β基因的调节有关。与水溶液中的PFD相比,PL更有效地抑制角膜组织中TGF-β的表达并恢复正常的IL-1β表达。总之,PFD在碱烧伤治疗中显示出重要的抗炎和抗纤维化作用。值得注意的是,一种新的载有PFD的脂质体制剂显著改善了这些作用,成为治疗角膜混浊的一种有前景的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5db/8875218/d19a385844ef/pharmaceutics-14-00316-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5db/8875218/9adea58a16bb/pharmaceutics-14-00316-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5db/8875218/eba1b5830c42/pharmaceutics-14-00316-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5db/8875218/0f9fb5981140/pharmaceutics-14-00316-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5db/8875218/0146ac5fa45e/pharmaceutics-14-00316-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5db/8875218/719843f60d9b/pharmaceutics-14-00316-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5db/8875218/d19a385844ef/pharmaceutics-14-00316-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5db/8875218/9adea58a16bb/pharmaceutics-14-00316-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5db/8875218/eba1b5830c42/pharmaceutics-14-00316-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5db/8875218/0f9fb5981140/pharmaceutics-14-00316-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5db/8875218/0146ac5fa45e/pharmaceutics-14-00316-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5db/8875218/719843f60d9b/pharmaceutics-14-00316-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5db/8875218/d19a385844ef/pharmaceutics-14-00316-g006.jpg

相似文献

1
Topical Pirfenidone-Loaded Liposomes Ophthalmic Formulation Reduces Haze Development after Corneal Alkali Burn in Mice.局部用载有吡非尼酮的脂质体眼用制剂可减少小鼠角膜碱烧伤后的混浊形成。
Pharmaceutics. 2022 Jan 28;14(2):316. doi: 10.3390/pharmaceutics14020316.
2
Controlled delivery of pirfenidone through vitamin E-loaded contact lens ameliorates corneal inflammation.通过负载维生素 E 的隐形眼镜控制递送达比非尼酮可改善角膜炎症。
Drug Deliv Transl Res. 2018 Oct;8(5):1114-1126. doi: 10.1007/s13346-018-0541-5.
3
Pirfenidone nanoparticles improve corneal wound healing and prevent scarring following alkali burn.吡非尼酮纳米粒可改善碱烧伤后角膜伤口愈合,预防瘢痕形成。
PLoS One. 2013 Aug 5;8(8):e70528. doi: 10.1371/journal.pone.0070528. Print 2013.
4
Nanostructured lipid carriers containing rapamycin for prevention of corneal fibroblasts proliferation and haze propagation after burn injuries: In vitro and in vivo.载雷帕霉素的纳米结构脂质载体预防烧伤后角膜成纤维细胞增殖和混浊发展:体内外研究。
J Cell Physiol. 2019 Apr;234(4):4702-4712. doi: 10.1002/jcp.27243. Epub 2018 Sep 7.
5
The Wound Healing Effects of Adiponectin Eye Drops after Corneal Alkali Burn.脂联素滴眼液对角膜碱烧伤后的伤口愈合作用
Curr Eye Res. 2016 Nov;41(11):1424-1432. doi: 10.3109/02713683.2015.1133834. Epub 2016 May 9.
6
Treatment for chemical burning using liquid crystalline nanoparticles as an ophthalmic delivery system for pirfenidone.采用液晶纳米粒作为眼科递药系统治疗化学烧伤的吡非尼酮。
Int J Pharm. 2019 Sep 10;568:118466. doi: 10.1016/j.ijpharm.2019.118466. Epub 2019 Jun 26.
7
Topical Ophthalmic Formulation of Trichostatin A and SurR9-C84A for Quick Recovery Post-alkali Burn of Corneal Haze.曲古抑菌素A和SurR9-C84A的局部眼用制剂用于碱烧伤后角膜混浊的快速恢复
Front Pharmacol. 2017 May 5;8:223. doi: 10.3389/fphar.2017.00223. eCollection 2017.
8
An ophthalmic solution of a peroxisome proliferator-activated receptor gamma agonist prevents corneal inflammation in a rat alkali burn model.过氧化物酶体增殖物激活受体γ激动剂的眼科溶液可预防大鼠碱烧伤模型中的角膜炎症。
Mol Vis. 2013 Nov 1;19:2135-50. eCollection 2013.
9
Therapeutic Effect of Topical Adiponectin-Derived Short Peptides Compared with Globular Adiponectin in Experimental Dry Eye and Alkali Burn.脂联素衍生短肽与球形脂联素在实验性干眼和碱烧伤中的治疗效果比较。
J Ocul Pharmacol Ther. 2020 Mar;36(2):88-96. doi: 10.1089/jop.2018.0131. Epub 2019 Oct 30.
10
Assessment of Topical Therapies for Improving the Optical Clarity Following Stromal Wounding in a Novel Ex Vivo Canine Cornea Model.评估局部治疗在新型离体犬角膜模型中改善基质创伤后光学清晰度的效果。
Invest Ophthalmol Vis Sci. 2018 Nov 1;59(13):5509-5521. doi: 10.1167/iovs.17-23085.

引用本文的文献

1
Nanovesicular Drug Delivery Systems for Rare Ocular Diseases: Advances, Challenges, and Future Directions.用于罕见眼科疾病的纳米囊泡给药系统:进展、挑战与未来方向
AAPS PharmSciTech. 2025 Jul 23;26(7):197. doi: 10.1208/s12249-025-03159-8.
2
Exploration of the optimal concentration of quercetin liposome nanoparticles for the treatment of liver damage.探索槲皮素脂质体纳米粒治疗肝损伤的最佳浓度。
BMC Pharmacol Toxicol. 2025 May 28;26(1):112. doi: 10.1186/s40360-025-00951-x.
3
Development of an Ophthalmic Hydrogel to Deliver MG53 and Promote Corneal Wound Healing.

本文引用的文献

1
Lipid-Based Nanocarriers as Topical Drug Delivery Systems for Intraocular Diseases.基于脂质的纳米载体作为眼部疾病的局部给药系统
Pharmaceutics. 2021 May 9;13(5):678. doi: 10.3390/pharmaceutics13050678.
2
Liposomes as vehicles for topical ophthalmic drug delivery and ocular surface protection.脂质体作为眼部局部药物递送和眼表面保护的载体。
Expert Opin Drug Deliv. 2021 Jul;18(7):819-847. doi: 10.1080/17425247.2021.1872542. Epub 2021 Jan 22.
3
Corneal myofibroblasts and fibrosis.角膜成纤维细胞与纤维化。
一种用于递送MG53并促进角膜伤口愈合的眼科水凝胶的研发。
Pharmaceutics. 2025 Apr 16;17(4):526. doi: 10.3390/pharmaceutics17040526.
4
Progress in Nanotechnology for Treating Ocular Surface Chemical Injuries: Reflecting on Advances in Ophthalmology.用于治疗眼表化学伤的纳米技术进展:眼科进展反思
Adv Sci (Weinh). 2025 Feb;12(6):e2407340. doi: 10.1002/advs.202407340. Epub 2025 Jan 4.
5
[Corneal wound healing-Pharmacological treatment].[角膜伤口愈合——药物治疗]
Ophthalmologie. 2024 Mar;121(3):245-258. doi: 10.1007/s00347-024-02021-9. Epub 2024 Feb 27.
6
Modulation of Extracellular Matrix Composition and Chronic Inflammation with Pirfenidone Promotes Scar Reduction in Retinal Wound Repair.吡非尼酮通过调节细胞外基质组成和慢性炎症促进视网膜伤口修复中的瘢痕减少。
Cells. 2024 Jan 16;13(2):164. doi: 10.3390/cells13020164.
7
Therapeutic applications of contact lens-based drug delivery systems in ophthalmic diseases.接触镜给药系统在眼科疾病治疗中的应用。
Drug Deliv. 2023 Dec;30(1):2219419. doi: 10.1080/10717544.2023.2219419.
Exp Eye Res. 2020 Dec;201:108272. doi: 10.1016/j.exer.2020.108272. Epub 2020 Sep 30.
4
Management Strategies of Ocular Chemical Burns: Current Perspectives.眼部化学烧伤的管理策略:当前观点
Clin Ophthalmol. 2020 Sep 15;14:2687-2699. doi: 10.2147/OPTH.S235873. eCollection 2020.
5
Topical Triamcinolone Acetonide-Loaded Liposomes as Primary Therapy for Macular Edema Secondary to Branch Retinal Vein Occlusion: A Pilot Study.载曲安奈德的脂质体局部给药治疗分支型视网膜静脉阻塞继发黄斑水肿:一项初步研究。
J Ocul Pharmacol Ther. 2020 Jul/Aug;36(6):393-403. doi: 10.1089/jop.2019.0143. Epub 2020 Jun 17.
6
A Novel CD147 Inhibitor, SP-8356, Attenuates Pathological Fibrosis in Alkali-Burned Rat Cornea.一种新型 CD147 抑制剂 SP-8356 可减轻碱烧伤大鼠角膜病理性纤维化。
Int J Mol Sci. 2020 Apr 23;21(8):2990. doi: 10.3390/ijms21082990.
7
Pirfenidone ameliorates the formation of choroidal neovascularization in mice.吡非尼酮可改善小鼠脉络膜新生血管的形成。
Mol Med Rep. 2020 May;21(5):2162-2170. doi: 10.3892/mmr.2020.11007. Epub 2020 Feb 27.
8
Biology of corneal fibrosis: soluble mediators, integrins, and extracellular vesicles.角膜纤维化的生物学:可溶性介质、整合素和细胞外囊泡。
Eye (Lond). 2020 Feb;34(2):271-278. doi: 10.1038/s41433-019-0736-0. Epub 2019 Dec 12.
9
Corneal injury: Clinical and molecular aspects.角膜损伤:临床与分子方面。
Exp Eye Res. 2019 Sep;186:107709. doi: 10.1016/j.exer.2019.107709. Epub 2019 Jun 22.
10
An update on chemical eye burns.眼部化学灼伤的最新进展
Eye (Lond). 2019 Sep;33(9):1362-1377. doi: 10.1038/s41433-019-0456-5. Epub 2019 May 13.